Table 5 Cumulative exposure adjusted event rates for the most frequent serious infections (n ⩾2) by preferred term after three years of anakinra exposure (without steroid use at baseline v with steroid use at baseline).
Without corticosteroid use at baseline | With corticosteroid use at baseline | ||||
---|---|---|---|---|---|
(n = 569) (E = 940.3) | (n = 777) (E = 1332.7) | ||||
Preferred term | n | EAE rate* | Preferred term | n | EAE rate* |
Any | 27 | 2.87 | Any | 95 | 7.13 |
Pneumonia | 9 | 0.96 | Pneumonia | 20 | 1.50 |
Cellulitis | 2 | 0.21 | Cellulitis | 16 | 1.20 |
Diverticulitis | 2 | 0.21 | Infection | 9 | 0.68 |
Lower respiratory infection | 2 | 0.21 | Sepsis | 5 | 0.38 |
Abscess abdomen | 3 | 0.23 | |||
Bronchitis | 3 | 0.23 | |||
Infection bacterial | 3 | 0.23 | |||
Osteomyelitis | 3 | 0.23 | |||
Pneumonia lobar | 3 | 0.23 | |||
Gastroenteritis | 2 | 0.15 | |||
Pneumonia bacterial | 2 | 0.15 | |||
Pyelonephritis | 2 | 0.15 | |||
Upper respiratory infection | 2 | 0.15 |
*Number of events per 100 patient‐years.
E, number of patient‐years of exposure; EAE, exposure adjusted event.